1906 | Humans |
1596 | HIV Infections |
1424 | Female |
1258 | Male |
1112 | Adult |
777 | South Africa |
655 | Adolescent |
619 | Middle Aged |
590 | Young Adult |
501 | Socioeconomic Factors |
347 | Anti-HIV Agents |
331 | Acquired Immunodeficiency Syndrome |
292 | Africa South of the Sahara |
290 | Risk Factors |
284 | Prevalence |
268 | Cross-Sectional Studies |
266 | Child |
261 | HIV-1 |
242 | Surveys and Questionnaires |
242 | Health Knowledge, Attitudes, Practice |
225 | Sexual Behavior |
207 | Pregnancy |
205 | CD4 Lymphocyte Count |
194 | Antiretroviral Therapy, Highly Active |
163 | AIDS-Related Opportunistic Infections |
152 | Anti-Retroviral Agents |
151 | Infant |
144 | Sexual Partners |
143 | Viral Load |
140 | Rural Population |
140 | Aged |
138 | Child, Preschool |
136 | Health Services Accessibility |
133 | Zambia |
132 | Developing Countries |
131 | Infectious Disease Transmission, Vertical |
128 | Qualitative Research |
124 | Patient Acceptance of Health Care |
120 | Risk-Taking |
117 | Tuberculosis |
117 | Interviews as Topic |
115 | Medication Adherence |
113 | HIV Seropositivity |
111 | Pregnancy Complications, Infectious |
110 | Treatment Outcome |
110 | Cohort Studies |
108 | Social Support |
106 | Incidence |
105 | Counseling |
100 | Prospective Studies |
99 | Condoms |
95 | Social Stigma |
92 | Sex Factors |
91 | Infant, Newborn |
90 | Retrospective Studies |
84 | Poverty |
83 | Age Factors |
82 | Uganda |
81 | Africa |
78 | Focus Groups |
77 | Mass Screening |
75 | Logistic Models |
71 | Urban Population |
70 | AIDS Serodiagnosis |
67 | HIV |
63 | Time Factors |
60 | Program Evaluation |
60 | Kenya |
57 | Health Surveys |
57 | Ghana |
56 | Follow-Up Studies |
56 | Caregivers |
54 | Health Policy |
54 | Family Characteristics |
52 | Zimbabwe |
52 | Delivery of Health Care |
52 | Attitude to Health |
50 | Health Education |
50 | Antitubercular Agents |
49 | Quality of Life |
48 | Population Surveillance |
47 | Sexually Transmitted Diseases |
47 | Patient Compliance |
47 | Disease Outbreaks |
46 | Mothers |
46 | African Continental Ancestry Group |
45 | Tanzania |
45 | Malawi |
45 | Educational Status |
44 | Prejudice |
44 | Multivariate Analysis |
44 | Global Health |
44 | Coinfection |
43 | Unsafe Sex |
43 | Stereotyping |
42 | Longitudinal Studies |
42 | Demography |
42 | AIDS Vaccines |
41 | Tuberculosis, Pulmonary |
41 | Health Promotion |
40 | Homosexuality, Male |
39 | Interpersonal Relations |
38 | RNA, Viral |
38 | Health Services Needs and Demand |
38 | Culture |
37 | Randomized Controlled Trials as Topic |
37 | Nigeria |
37 | Child, Orphaned |
36 | Genotype |
36 | Disease Progression |
36 | Circumcision, Male |
36 | Age Distribution |
35 | Community Health Services |
34 | Truth Disclosure |
34 | Risk Assessment |
34 | Mycobacterium tuberculosis |
34 | Alcohol Drinking |
34 | Aged, 80 and over |
33 | Virus Diseases |
33 | Senegal |
33 | Motivation |
33 | Drug Resistance, Viral |
33 | Depression |
33 | Case-Control Studies |
33 | Adaptation, Psychological |
32 | Sex Distribution |
32 | Pilot Projects |
32 | Health Personnel |
32 | Disease |
32 | Animals |
31 | Tenofovir |
31 | Residence Characteristics |
31 | Drug Therapy, Combination |
30 | Social Class |
30 | Regression Analysis |
30 | Primary Health Care |
30 | Politics |
30 | International Cooperation |
30 | Communication |
29 | United States |
29 | Prenatal Care |
29 | Odds Ratio |
29 | Models, Theoretical |
29 | Economics |
29 | Cost-Benefit Analysis |
29 | Clinical Trials as Topic |
28 | Vulnerable Populations |
28 | Risk Reduction Behavior |
27 | Women's Health |
27 | Adolescent Behavior |
26 | Safe Sex |
26 | Health Status |
26 | Comorbidity |
26 | Attitude of Health Personnel |
26 | Ambulatory Care Facilities |
25 | Stress, Psychological |
25 | Public Health |
25 | Home Care Services |
25 | Cause of Death |
25 | Breast Feeding |
25 | Africa, Southern |
24 | Survival Analysis |
24 | Substance-Related Disorders |
24 | Sex Work |
24 | Rural Health |
24 | Nevirapine |
24 | Health Behavior |
24 | CD4-Positive T-Lymphocytes |
23 | Family |
23 | Ethiopia |
23 | Epidemics |
22 | Phylogeny |
22 | Drug Administration Schedule |
22 | Decision Making |
21 | Transients and Migrants |
21 | Social Environment |
21 | Perception |
21 | Mental Disorders |
21 | Health Services Research |
21 | HIV Seroprevalence |
21 | Epidemiologic Methods |
21 | Communicable Disease Control |
20 | World Health Organization |
20 | Schools |
20 | Sarcoma, Kaposi |
20 | Reproducibility of Results |
20 | Population |
20 | Health Services |
20 | Feasibility Studies |
20 | Cultural Characteristics |
20 | Africa, Eastern |
20 | AIDS Dementia Complex |
19 | gag Gene Products, Human Immunodeficiency Virus |
19 | Severity of Illness Index |
19 | Meningitis, Cryptococcal |
19 | Medicine, African Traditional |
19 | Botswana |
18 | Sequence Analysis, DNA |
18 | Reverse Transcriptase Inhibitors |
18 | Research Design |
18 | Population Dynamics |
18 | Patient Education as Topic |
18 | Organophosphonates |
18 | Mortality |
18 | Marriage |
18 | Isoniazid |
18 | HIV Antibodies |
18 | Food Supply |
18 | Data Collection |
18 | Cost of Illness |
18 | Cluster Analysis |
18 | Adenine |
17 | Students |
17 | Spouse Abuse |
17 | Sex Education |
17 | Sensitivity and Specificity |
17 | Proportional Hazards Models |
17 | Neoplasms |
17 | Molecular Sequence Data |
17 | Family Planning Services |
17 | Community Networks |
17 | Community Health Workers |
17 | Child of Impaired Parents |
17 | Benzoxazines |
16 | Treatment Failure |
16 | Swaziland |
16 | Sex Workers |
16 | Self Report |
16 | Rural Health Services |
16 | Risk |
16 | Research |
16 | Preventive Health Services |
16 | Pre-Exposure Prophylaxis |
16 | Parents |
16 | Mutation |
16 | Income |
16 | Heterosexuality |
16 | Health Care Surveys |
16 | Genetic Variation |
16 | Employment |
16 | Education |
16 | Disclosure |
16 | Ambulatory Care |
15 | Women |
15 | Self Efficacy |
15 | Self Disclosure |
15 | Psychiatric Status Rating Scales |
15 | Program Development |
15 | Prognosis |
15 | Maternal Health Services |
15 | Marital Status |
15 | Immune Reconstitution Inflammatory Syndrome |
15 | Confidentiality |
15 | Anti-Infective Agents |
14 | Uterine Cervical Neoplasms |
14 | United Nations |
14 | Sputum |
14 | Pregnant Women |
14 | Practice Guidelines as Topic |
14 | National Health Programs |
14 | Mental Health |
14 | Malnutrition |
14 | History, 20th Century |
14 | Health Status Disparities |
14 | Enzyme-Linked Immunosorbent Assay |
14 | Body Mass Index |
14 | Asia |
14 | Antifungal Agents |
13 | Voluntary Programs |
13 | Tuberculosis, Multidrug-Resistant |
13 | Sex Offenses |
13 | Referral and Consultation |
13 | Quality of Health Care |
13 | Namibia |
13 | Maternal Mortality |
13 | Lost to Follow-Up |
13 | Lamivudine |
13 | Kaplan-Meier Estimate |
13 | Hepatitis B |
13 | Health Resources |
13 | Health Facilities |
13 | Health Care Costs |
13 | HIV Seronegativity |
13 | HIV Protease Inhibitors |
13 | Emigrants and Immigrants |
13 | Discrimination (Psychology) |
13 | Chronic Disease |
13 | Cameroon |
13 | CD8-Positive T-Lymphocytes |
13 | Biomarkers |
13 | Algorithms |
13 | Administration, Intravaginal |
12 | Viremia |
12 | Vaginal Creams, Foams, and Jellies |
12 | Trimethoprim, Sulfamethoxazole Drug Combination |
12 | Substance Abuse, Intravenous |
12 | Seroepidemiologic Studies |
12 | Sampling Studies |
12 | Rwanda |
12 | Professional-Patient Relations |
12 | Power (Psychology) |
12 | Policy Making |
12 | Peer Group |
12 | Needs Assessment |
12 | Morbidity |
12 | Microbial Sensitivity Tests |
12 | Malaria |
12 | Human Rights |
12 | Hospitalization |
12 | Fear |
12 | Evaluation Studies as Topic |
12 | Depressive Disorder |
12 | Cryptococcosis |
12 | Cote d'Ivoire |
12 | Child Welfare |
12 | Burkina Faso |
12 | Alcoholism |
11 | Zidovudine |
11 | Women's Rights |
11 | Urban Health |
11 | Universities |
11 | Thailand |
11 | Spouses |
11 | Religion |
11 | Population Characteristics |
11 | Patient Selection |
11 | Outcome Assessment (Health Care) |
11 | Healthcare Disparities |
11 | HIV-2 |
11 | Family Health |
11 | Emigration and Immigration |
11 | Early Diagnosis |
11 | Disease Transmission, Infectious |
11 | Contraception |
11 | Communicable Diseases |
11 | Child Health Services |
11 | Anti-Bacterial Agents |
10 | Social Conditions |
10 | Social Behavior |
10 | Ritonavir |
10 | Poverty Areas |
10 | Polymorphism, Single Nucleotide |
10 | Organization and Administration |
10 | Models, Statistical |
10 | Lopinavir |
10 | Leadership |
10 | Intention |
10 | Health Expenditures |
10 | Gender Identity |
10 | Forecasting |
10 | Flow Cytometry |
10 | Domestic Violence |
10 | Disabled Persons |
10 | Diabetes Mellitus |
10 | Cross-Cultural Comparison |
10 | Congresses as Topic |
10 | Confidence Intervals |
10 | Community Participation |
10 | Child Mortality |
10 | Biomedical Research |
10 | Behavior |
10 | Antibodies, Viral |
10 | Africa, Western |
9 | pol Gene Products, Human Immunodeficiency Virus |
9 | Stavudine |
9 | Social Perception |
9 | Sexuality |
9 | Psychometrics |
9 | Polymorphism, Genetic |
9 | Polymerase Chain Reaction |
9 | Parent-Child Relations |
9 | Neuropsychological Tests |
9 | Mozambique |
9 | Lesotho |
9 | Kidney Diseases |
9 | Informed Consent |
9 | Information Dissemination |
9 | Infant Mortality |
9 | History, 21st Century |
9 | Herpesvirus 8, Human |
9 | Health Planning |
9 | Geography |
9 | Genetic Predisposition to Disease |
9 | Financing, Organized |
9 | Fertility |
9 | Drug Interactions |
9 | Double-Blind Method |
9 | Directive Counseling |
9 | Diarrhea |
9 | Democratic Republic of the Congo |
9 | Cryptococcus neoformans |
9 | Cooperative Behavior |
9 | Cognitive Therapy |
9 | Chi-Square Distribution |
9 | Body Weight |
8 | Virus Replication |
8 | Violence |
8 | Travel |
8 | Social Problems |
8 | Sentinel Surveillance |
8 | Self Concept |
8 | Self Care |
8 | Public Sector |
8 | Public Policy |
8 | Psychology |
8 | Postpartum Period |
8 | Patient Satisfaction |
8 | Palliative Care |
8 | Organizations |
8 | Obesity |
8 | Nutritional Status |
8 | Nurses |
8 | Molecular Epidemiology |
8 | Models, Biological |
8 | Military Personnel |
8 | Interferon-gamma |
8 | India |
8 | Hypertension |
8 | Hospitals, University |
8 | Hospitals, Teaching |
8 | Hepatitis C |
8 | Hepatitis B Surface Antigens |
8 | Health Priorities |
8 | HIV Reverse Transcriptase |
8 | France |
8 | Family Relations |
8 | European Continental Ancestry Group |
8 | Ethnic Groups |
8 | Endemic Diseases |
8 | Early Detection of Cancer |
8 | Drug Monitoring |
8 | Developed Countries |
8 | Delivery of Health Care, Integrated |
8 | DNA, Viral |
8 | Cytokines |
8 | Clinical Protocols |
8 | Cardiovascular Diseases |
8 | Attitude |
8 | Anxiety |
8 | Anxiety Disorders |
8 | Anthropology, Cultural |
8 | Analysis of Variance |
8 | Aging |
8 | Africa, Northern |
7 | env Gene Products, Human Immunodeficiency Virus |
7 | Tertiary Care Centers |
7 | Syphilis |
7 | Survival Rate |
7 | Stress Disorders, Post-Traumatic |
7 | Social Change |
7 | Recurrence |
7 | Predictive Value of Tests |
7 | Postnatal Care |
7 | Post-Exposure Prophylaxis |
7 | Pain |
7 | Mutation, Missense |
7 | Mining |
7 | Lymphocyte Activation |
7 | Hospitals, Public |
7 | Health |
7 | Government Programs |
7 | Genetic Vectors |
7 | Faculty |
7 | Extensively Drug-Resistant Tuberculosis |
7 | Emtricitabine |
7 | Diet |
7 | Diagnostic Tests, Routine |
7 | Databases, Factual |
7 | Continuity of Patient Care |
7 | Chemoprevention |
7 | Cell Phones |
7 | Bayes Theorem |
7 | Autopsy |
7 | Antiviral Agents |
7 | Antibodies, Neutralizing |
7 | Activities of Daily Living |
7 | AIDS-Associated Nephropathy |
6 | nef Gene Products, Human Immunodeficiency Virus |
6 | Widowhood |
6 | Weight Gain |
6 | Vaginal Douching |
6 | Unemployment |
6 | T-Lymphocytes |
6 | Social Welfare |
6 | Social Responsibility |
6 | Social Justice |
6 | Smoking |
6 | Sexual Abstinence |
6 | Resource Allocation |
6 | Resilience, Psychological |
6 | Reproductive Health Services |
6 | Receptors, CCR5 |
6 | Rape |
6 | Public Health Surveillance |
6 | Public Health Administration |
6 | Primary Prevention |
6 | Point-of-Care Systems |
6 | Pneumonia, Pneumocystis |
6 | Plant Extracts |
6 | Phytotherapy |